...The total impact of a foreign exchange rate on revenue was JPY51.3 billion. Slide 6, shows the factors behind the increase or decrease in core operating profit. As explained earlier, revenue increased by JPY284.6 billion, including JPY51.2 billion increase due to falling exchange effects, and this shows the breakdown of the increase of revenue JPY100 billion to JPY17.6 billion. Next, I will explain cost of sales and expenses, excluding the effect of foreign exchange rates. Cost of sales decreased by JPY9.8 billion due to an improvement in the cost of sales ratio, despite an increase in revenue, reflecting an increase in sales of in-house developed products such as air hearts, a change in the product mix due to the no longer including sales of that [San S5] products. And an increase in development and sales milestone income from strategically collaborated products. SG&A expenses increased by JPY71.9 billion, mainly due to an increase in profit sharing with AstraZeneca in relation to NH....
